132 Recruiting Now

Psychedelic Clinical Trials

Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.

Showing 241262 of 262 trials
Unknown·Phase 2·psilocybin

Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans

Combat Stress

PTSD
Unknown·Phase 2·psilocybin

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Halucenex Life Sciences Inc.

Treatment Resistant DisordersPost Traumatic Stress Disorder
Unknown·N/A·psilocybin

Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action

Imperial College London

Fibromyalgia
Unknown·Phase 2·psilocybin

Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

Clairvoyant Therapeutics

Alcohol Use Disorder
Unknown·Phase 2·psilocybin

Psilocybin Versus Ketamine in Treatment-Resistant Depression

National Institute of Mental Health, Czech Republic

Treatment Resistant Depression
Unknown·Phase 2·psilocybin

The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

Sheppard Pratt Health System

Treatment Resistant Depression
Unknown·Phase 2·psilocybin

Psilocybin in Depression Resistant to Standard Treatments

King's College London

Treatment Resistant Depression
Unknown·Phase 2·psilocybin

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Maryland Oncology Hematology, PA

Major Depressive Disorder
Unknown·Phase 2·psilocybin

Psilocybin and Depression

University of Helsinki

Severe Depression
Withdrawn·Phase 2·psilocybin

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

Johns Hopkins University

Opioid Use Disorder
Withdrawn·Phase 2·psilocybin

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

University of New Mexico

Suicidal Ideation
Withdrawn·Phase 1·psilocybin

Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder

Johns Hopkins University

Post-Traumatic Stress Disorder
Withdrawn·N/A·psilocybin

Optimizing Microdosing and Meditation

National University of Natural Medicine

MeditationMicrodosing
Withdrawn·Phase 2·psilocybin

Psilocybin for Major Depressive Disorder

Washington University School of Medicine

Major Depressive Disorder
Withdrawn·Phase 2·psilocybin

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Johns Hopkins University

Opioid Use Disorder
Withdrawn·Early Phase 1·psilocybin

Exploratory Study of Low Dose Psilocybin

University of Alabama at Birmingham

Demoralization
Withdrawn·Phase 2·psilocybin

PET Synaptogenesis After Psilocybin In DEpression Recovery

Washington University School of Medicine

Major Depressive DisorderAnhedonia
Withdrawn·Phase 1·psilocybin

Bioavailability Study of Psilocybin in Normal Adults

University of Wisconsin, Madison

Healthy
Withdrawn·Phase 2·psilocybin

Effect of SSRIs on Response to Psilocybin Therapy

Cybin Therapeutics Inc.

DepressionMajor Depressive DisorderMild Depression+2 more
Withdrawn·Early Phase 1·psilocybin

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Optimi Health Corporation

Mood DisturbanceMood ChangeSleep Disturbance+7 more
Withdrawn·Phase 2·psilocybin

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

Massachusetts General Hospital

Treatment-Resistant Major Depressive Disorder
Withdrawn·Phase 2·psilocybin

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Multidisciplinary Association for Psychedelic Studies

AnxietyStage IV Melanoma
PreviousPage 6 of 6

Browse by Condition

View all conditions →

How to Join a Clinical Trial

Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.

1. Review

Read the trial details, eligibility criteria, and what participation involves.

2. Contact

Reach out to the study team using the contact information provided.

3. Screen

Complete the screening process to determine if you're eligible.